title: Adverse effect profile of trichlormethiazide: a retrospective observational study.
abstract: BACKGROUND
  Trichlormethiazide, a thiazide diuretic, was introduced in 1960 and remains one of the most frequently used diuretics for treating hypertension in Japan. While numerous clinical trials have indicated important side effects of thiazides, e.g., adverse effects on electrolytes and uric acid, very few data exist on serum electrolyte levels in patients with trichlormethiazide treatment. We performed a retrospective cohort study to assess the adverse effects of trichlormethiazide, focusing on serum electrolyte and uric acid levels.
  
  
  METHODS
  We used data from the Clinical Data Warehouse of Nihon University School of Medicine obtained between Nov 1, 2004 and July 31, 2010, to identify cohorts of new trichlormethiazide users (n = 99 for 1 mg, n = 61 for 2 mg daily dosage) and an equal number of non-users (control). We used propensity-score matching to adjust for differences between users and control for each dosage, and compared serum chemical data including serum sodium, potassium, uric acid, creatinine and urea nitrogen. The mean exposure of trichlormethiazide of 1 mg and 2 mg users was 58 days and 64 days, respectively.
  
  
  RESULTS
  The mean age was 66 years, and 55% of trichlormethiazide users of the 1 mg dose were female. In trichlormethiazide users of the 2 mg dose, the mean age was 68 years, and 43% of users were female. There were no statistically significant differences in all covariates (age, sex, comorbid diseases, past drugs, and current antihypertensive drugs) between trichlormethiazide users and controls for both doses. In trichlormethiazide users of the 2 mg dose, the reduction of serum potassium level and the elevation of serum uric acid level were significant compared with control, whereas changes of mean serum sodium, creatinine and urea nitrogen levels were not significant. In trichlormethiazide users of the 1 mg dose, all tests showed no statistically significant change from baseline to during the exposure period in comparison with control.
  
  
  CONCLUSIONS
  Our study showed adverse effects of decreased serum potassium and increased serum uric acid with trichlormethiazide treatment, and suggested that a lower dose of trichlormethiazide may minimize these adverse effects. These findings support the current trend in hypertension therapeutics to shift towards lower doses of thiazides.
authors: Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
authors: Yasuo
authors: Y
authors: Takahashi
authors: Yayoi
authors: Y
authors: Nishida
authors: Tomohiro
authors: T
authors: Nakayama
authors: Satoshi
authors: S
authors: Asai
references: Am J Cardiovasc Drugs. 2005;5(1):17-22
references: 15631534
references: J Am Med Assoc. 1958 Jan 11;166(2):137-40
references: 13491319
references: Br J Clin Pharmacol. 2006 Jan;61(1):87-95
references: 16390355
references: J Hypertens. 2007 Jun;25(6):1105-87
references: 17563527
references: JAMA. 1991 Jun 26;265(24):3255-64
references: 2046107
references: Cardiovasc Diabetol. 2009 Mar 27;8:18
references: 19327149
references: Hypertension. 2011 Apr;57(4):689-94
references: 21383313
references: Hypertension. 2003 Dec;42(6):1206-52
references: 14656957
references: Value Health. 2009 Nov-Dec;12(8):1053-61
references: 19744292
references: Hypertens Res. 2006 Nov;29(11):857-63
references: 17345785
references: Diabetol Metab Syndr. 2010 Jun 24;2(1):44
references: 20576135
references: N Engl J Med. 2009 Nov 26;361(22):2153-64
references: 19940300
references: J Clin Pharmacol. 1991 Aug;31(8):751-7
references: 1880234
references: Hypertension. 1999 Nov;34(5):1129-33
references: 10567194
references: Cardiovasc Diabetol. 2007 Sep 29;6:26
references: 17903269
references: Hypertension. 2000 May;35(5):1025-30
references: 10818057
references: Hypertens Res. 2009 Nov;32(11):962-8
references: 19696778
references: Arch Intern Med. 1997 Mar 24;157(6):638-48
references: 9080918
references: Cardiol Rev. 2010 Jan-Feb;18(1):51-6
references: 20010338
references: Am J Cardiol. 1959 Feb;3(2):214-9
references: 13626851
references: JAMA. 2002 Dec 18;288(23):2981-97
references: 12479763
references: J Clin Hypertens (Greenwich). 2007 Jan;9(1):45-8
references: 17215658
references: N Engl J Med. 2000 Jun 22;342(25):1887-92
references: 10861325
references: Cardiovasc Diabetol. 2010 Aug 16;9:38
references: 20712859
references: QJM. 2003 Dec;96(12):911-7
references: 14631057
references: J Clin Epidemiol. 2008 Jun;61(6):537-45
references: 18471657